AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.2B |
| 2 |
Zebra Technologies
ZBRA
|
+$682M |
| 3 |
Autodesk
ADSK
|
+$664M |
| 4 |
Entegris
ENTG
|
+$646M |
| 5 |
Nike
NKE
|
+$560M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.47B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$1.39B |
| 3 |
Take-Two Interactive
TTWO
|
+$590M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$383M |
| 5 |
Verisk Analytics
VRSK
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.99% |
| 2 | Healthcare | 16.08% |
| 3 | Consumer Discretionary | 12.25% |
| 4 | Financials | 11.95% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ENDP
2501
DELISTED
Endo International plc
ENDP
| $800K | ﹤0.01% |
346,282
+767
| +0.2% | +$2.25K |
|
2502
Liberty Global Class C
LBTYK
$3.45B
| $798K | ﹤0.01% |
30,783
+5,047
| +20% | +$135K |
|
|
HIBB
2503
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $798K | ﹤0.01% |
18,008
-2,533
| -12% | -$137K |
|
2504
Xometry
XMTR
$4.49B
| $797K | ﹤0.01% |
+21,700
| New | +$992K |
|
|
AAN
2505
DELISTED
The Aaron's Company Inc
AAN
| $789K | ﹤0.01% |
39,300
-6,049
| -13% | -$132K |
|
|
UHG
2506
DELISTED
United Homes Group
UHG
| $781K | ﹤0.01% |
79,812
| – | – |
|
|
VMEO
2507
DELISTED
Vimeo
VMEO
| $780K | ﹤0.01% |
65,637
-1,366
| -2% | -$18.2K |
|
2508
NRC Health Common Stock
NRC
$462M
| $778K | ﹤0.01% |
19,629
+5,060
| +35% | +$198K |
|
|
VERV
2509
DELISTED
Verve Therapeutics
VERV
| $778K | ﹤0.01% |
34,100
+20,300
| +147% | +$580K |
|
2510
Zumiez
ZUMZ
$335M
| $773K | ﹤0.01% |
20,225
-5,737
| -22% | -$249K |
|
2511
QCR Holdings
QCRH
$1.69B
| $772K | ﹤0.01% |
13,639
+7,200
| +112% | +$411K |
|
2512
First Mid Bancshares
FMBH
$1.41B
| $771K | ﹤0.01% |
20,037
-775
| -4% | -$31.9K |
|
2513
Organogenesis Holdings
ORGO
$322M
| $766K | ﹤0.01% |
100,579
+291
| +0.3% | +$2.25K |
|
2514
Fastly Inc
FSLY
$3.19B
| $757K | ﹤0.01% |
43,572
-2,189
| -5% | -$51.1K |
|
2515
Lyell Immunopharma
LYEL
$323M
| $755K | ﹤0.01% |
+7,473
| New | +$905K |
|
2516
nCino
NCNO
$2.05B
| $754K | ﹤0.01% |
18,401
-439,480
| -96% | -$20.1M |
|
2517
Pulmonx
LUNG
$52.8M
| $752K | ﹤0.01% |
30,300
| – | – |
|
|
AFAC
2518
DELISTED
Arena Fortify Acquisition Corp. Class A Common Stock
AFAC
| $751K | ﹤0.01% |
+75,000
| New | +$745K |
|
2519
MBIA
MBI
$279M
| $750K | ﹤0.01% |
48,759
+2,059
| +4% | +$30.3K |
|
2520
iShares Russell Mid-Cap Growth ETF
IWP
$19.5B
| $746K | ﹤0.01% |
7,422
+2,614
| +54% | +$260K |
|
|
SRNE
2521
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $746K | ﹤0.01% |
320,100
+900
| +0.3% | +$2.81K |
|
|
TMAC
2522
DELISTED
The Music Acquisition Corporation
TMAC
| $746K | ﹤0.01% |
76,500
| – | – |
|
2523
Douglas Dynamics
PLOW
$1B
| $744K | ﹤0.01% |
21,500
-700
| -3% | -$25.5K |
|
2524
Theravance Biopharma
TBPH
$875M
| $743K | ﹤0.01% |
77,735
+200
| +0.3% | +$1.96K |
|
2525
OptimizeRx
OPRX
$119M
| $738K | ﹤0.01% |
19,559
+25
| +0.1% | +$1.11K |
|
Similar funds
AllianceBernstein's Q1 2022 Portfolio in Review
As of Q1 2022, AllianceBernstein held 3,400 positions worth $259B, down 8.4% from $283B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
AllianceBernstein's Q1 2022 filing shows 107 new, 1,503 increased, 1,401 reduced and 139 closed positions. Its largest new stake was State Street Financial Select Sector SPDR ETF: 1,823,221 shares worth $69.9M. The largest sale was Meta Platforms (Facebook), an estimated $1.47B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- AllianceBernstein's largest Q1 2022 buy was State Street Financial Select Sector SPDR ETF: 1,823,221 shares worth $69.9M.
- AllianceBernstein added most to Advanced Micro Devices in Q1 2022, an estimated $1.2B increase.
- AllianceBernstein's biggest Q1 2022 reduction was Meta Platforms (Facebook), cutting an estimated $1.47B.
- AllianceBernstein fully exited Xilinx Inc in Q1 2022, selling an estimated $1.39B.
- AllianceBernstein's ten largest holdings make up 25% of its $259B portfolio in Q1 2022.
- AllianceBernstein opened 107 new positions and closed 139 in Q1 2022.
- AllianceBernstein's portfolio value fell 8.4% quarter-over-quarter to $259B.
Based on AllianceBernstein's 13F filing for Q1 2022, filed 13 May 2022.